Reply to Huang et al.: 'Segmental fructose handling may refine the temporal glucagon-like peptide-1/glucagon-like peptide-2 framework during chronic fructose exposure'.
Glucagon-like peptide-1 (GLP-1) and glucagon-like peptide-2 (GLP-2) aren’t just buzzwords in metabolic research—they’re anchors for understanding how the gut talks to the rest of the body. Murao’s reply to Huang et al. in J Physiol digs deeper into how the body’s peptide system handles fructose over time, especially when exposure is chronic.
J Physiol
by Murao N
“Reply to Huang et al.: 'Segmental fructose handling may refine the temporal glucagon-like peptide-1/glucagon-like peptide-2 framework during chronic fructose exposure'. Murao N(1)(2)(3). Author information: (1)Department of Endocrinology, Diabetes and Metabolism, Fujita Health University, School of Medicine, Toyoake, Japan. (2)Yutaka Seino Distinguished Center for Diabetes Research, Kansai Electric Power Medical Research Institute, Kyoto, Japan. (3)Institute for Diabetes and Organoid Technology, Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH), Neuherberg, Germany.”
The main idea: the gut doesn’t treat all sugar the same way, and that matters for how GLP-1 and GLP-2 get released. Fructose, compared to glucose, gets handled in segments as it moves through the intestine. That means the timing and location of peptide release can shift, especially after repeated exposure. Murao points out that this “segmental handling” could sharpen our models of how these peptides work in response to diet.
Why does this matter? Researchers have been trying to map out the exact triggers and timing for GLP-1 and GLP-2 for years. These peptides are tied to everything from appetite control to gut health and beyond. If fructose changes the release pattern, it could explain why different diets have such varied effects on metabolism and peptide signaling.
Key takeaways for the peptide research community:
Chronic fructose changes how and when GLP-1 and GLP-2 are released
Segmental handling highlights the gut’s complexity as a peptide release organ
This could reshape how researchers model peptide responses in nutritional studies
For anyone digging into gut peptides, these findings are a reminder to look past simple models. Real-world diets aren’t one-size-fits-all, and neither is peptide signaling. If you’re exploring the details of these mechanisms or sourcing peptides for lab work, check the peptide research index for more context and connections.
Peptide research keeps evolving—don’t blink or you’ll miss the next nuance.
Related Reading
The STRIDE Trial and Semaglutide: Implications for Clinical Vascular Practice.
News · J Med ChemStructure-Based Adaptation of a SARS-CoV-2 Neutralizing Peptide to New Virus Variants.
News · J Nucl MedCombining an α(v)β(6)-Targeted (177)Lu-Based Peptide Receptor Radionuclide Therapy with Olaparib to Boost Therapeutic Efficacy in Pancreatic Cancer.
For Research Use Only
All content published on Pushing Peptides is intended for educational and informational purposes only. The information provided is not intended as medical advice, diagnosis, or treatment. Peptides discussed in this article are research compounds and are not approved for human therapeutic use by the FDA or any other regulatory agency. All studies referenced involve animal models or in vitro research unless otherwise stated. Consult a qualified healthcare professional before making any decisions related to your health. Pushing Peptides does not sell peptides — we are a vendor directory and educational resource.